Skip to main content

Supplementary Figure S2 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

Publication ,  Other
Ludwig, AL; McKay, ZP; Carter, GP; Katz, MA; Howell, G; Jain, V; Arvai, S; Dittmer, DP; Bigner, DD; Ashley, DM; Shoaf, ML; Desjardins, A ...
February 3, 2026

<p>Supplementary Figure S2. Differences in gene expression and hallmark pathways between single-site (IT or CPLI) and dual-site (IT plus CPLI) treatment cohorts compared to mock treatment as shown.</p>

Duke Scholars

DOI

Publication Date

February 3, 2026
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ludwig, A. L., McKay, Z. P., Carter, G. P., Katz, M. A., Howell, G., Jain, V., … Gromeier, M. (2026). Supplementary Figure S2 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. https://doi.org/10.1158/2326-6066.31239131
Ludwig, Andrea L., Zachary P. McKay, Griffin P. Carter, Mark A. Katz, Georgia Howell, Vaibhav Jain, Stephanie Arvai, et al. “Supplementary Figure S2 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration,” February 3, 2026. https://doi.org/10.1158/2326-6066.31239131.
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M. Supplementary Figure S2 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. 2026.

DOI

Publication Date

February 3, 2026